Surmodics, Inc. (SRDX) delivered a return of 47.49% over the past year. Since SRDX does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Surmodics, Inc. one year ago would be worth $14,749 today, representing a gain of $4,749.

Surmodics, Inc. (SRDX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For SRDX, the total return equals the price-only return.

Yes, Surmodics, Inc. (SRDX) outperformed the S&P 500 by 22.50 percentage points over the past year. SRDX delivered a total return of 47.49%, compared to the S&P 500's 24.99%. This 22.50pp alpha means investors in SRDX earned more than a passive S&P 500 index fund.

Surmodics, Inc. (SRDX) experienced a maximum drawdown of -30.47% over the past year, declining from its peak on 2025-08-11 to its trough on 2025-11-06. The stock recovered to its prior peak by 2025-11-11. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Surmodics, Inc. (SRDX)'s long-term returns with dividends reinvested. Over 10 years, the total return is 83.9% (6.3% CAGR) — $10,000 would have grown to $18,391. Over 20 years: 10.8% total return (0.5% CAGR) — $10,000 → $11,083. Over 30 years: 958.0% total return (8.2% CAGR) — $10,000 → $105,796. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Surmodics, Inc.'s best calendar year was 2000 with a total return of 140.9%. Its worst year was 2008 with a total return of -53.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 194.3 percentage points.